ETHYL CAFFEATE b
CAS No. 102-37-4
ETHYL CAFFEATE b( ETHYL 34-DIHYDROXYCINNAMATE )
Catalog No. M20310 CAS No. 102-37-4
In vitro ECF suppressed the differentiation of naive CD4+ T cells into Th1. Furthermore ECF intensely blocked the transcriptional expression in interferon-γ-related signaling including IFN-γ T-bet STAT1 and STAT4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 115 | In Stock |
|
| 100MG | 184 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameETHYL CAFFEATE b
-
NoteResearch use only, not for human use.
-
Brief DescriptionIn vitro ECF suppressed the differentiation of naive CD4+ T cells into Th1. Furthermore ECF intensely blocked the transcriptional expression in interferon-γ-related signaling including IFN-γ T-bet STAT1 and STAT4.
-
DescriptionIn vitro ECF suppressed the differentiation of naive CD4+ T cells into Th1. Furthermore ECF intensely blocked the transcriptional expression in interferon-γ-related signaling including IFN-γ T-bet STAT1 and STAT4.
-
In VitroEthyl Caffeate markedly suppresses the lipopolysaccharide (LPS)-induced nitric oxide (NO) production with IC50 of 5.5?μg/ml.
-
In Vivo——
-
SynonymsETHYL 34-DIHYDROXYCINNAMATE
-
PathwayImmunology/Inflammation
-
TargetNOS
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number102-37-4
-
Formula Weight208.21
-
Molecular FormulaC11H12O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:41 mg/mL (196.91 mM)
-
SMILESCCOC(=O)\C=C\c1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shikui X Aixue Z Zengjun G et al. Ethyl Caffeate Ameliorates Collagen-Induced Arthritis by Suppressing Th1 Immune Response[J]. Journal of Immunology Research 2017 2017:1-11.
molnova catalog
related products
-
ZL-006
ZL-006 (ZL 006, ZL006) is a brain penetrant small molecule inhibitor of PSD-95/nNOS interaction that prevents glutamate-induced excitotoxicity and cerebral ischemic damage in vivo.
-
Syringin
Syringin has antitumour, antiproliferative, immunomodulatory and platelet aggregation inhibiting effects. Syringin can prevent Abeta(25-35)-induced neuronal cell damage.
-
MSU-42011
MSU-42011 is an orally active retinoid X receptor-like (RXR) agonist. It potently inhibits the expression of iNOS, low SREBP-induced and activated RXR, and p-ERK at the protein level.
Cart
sales@molnova.com